KSG is investigating claims for a lawsuit against Janssen Pharmaceuticals, Inc, a subsidiary of Johnson & Johnson Co. for its dangerous type 2 diabetes Drug, Invokana (canagliflozin) , a SGLT2 inhibitor antidiabetic. This drug’s primary purpose is to treat Type 2 Diabetes which hampers the body’s ability to process glucose for energy production. Unlike other types of diabetic drugs that affect the supply or use of insulin, Invokana removes sugar from blood via urine. However, Invokana has been reported to produce undesirable side-effects in some people. Although consumers expect to endure some undesired side-effects to gain the benefits of prescription drugs, the risks associated with the consumption of the drug should not be worse than the original condition.
Compared to safer alternatives, Invokana has a long list of extremely dangerous side effects. Since the FDA approved Invokana in March 2013, its side effects have grown continuously as doctors unknowingly prescribed the drug to patients seeking relief from Type 2 Diabetes. This list includes, but is not limited to, heart attack, kidney failure, increased amputation risk of extremities like feet and legs (due to an infection called gangrene, the spread of which can only be stopped via amputation), Urinary Tract Infection (UTI), and Ketoacidosis where acidic byproducts, called ketones, become toxic and potentially fatal.
Some have even alleged that Janssen Pharmaceuticals knew or should have known about these excessive side effects if not for recklessness. After all, Invokana is one of Janssen’s top selling drugs with sales of $278 million dollars in the first quarter of 2015 alone. Furthermore, they have claimed that the pharmaceutical company has failed its consumers who expect their products to produce the desired effect of improving their health; instead, Jenssen supposedly failed to fully disclose the true risks associated with taking Invokana and thus is responsible for causing potentially avoidable injuries. Yet, despite these dangers, the FDA nor Janssen has stopped producing its dangerous type 2 diabetes drug, Invokana, or mandated a recall. Something must be done before more innocent people are harmed.
If you have been suffering from serious conditions including but not limited to amputation of feet or leg, heart attack, kidney failure, Ketoacidosis, and UTI after ingesting the dangerous type 2 diabetes drug, Invokana, please contact us. You may be eligible for relief.. All initial consultations are free of charge.
Kohn, Swift & Graf is a national leader in class actions, including complex consumer litigation. With experienced attorneys and a competent support staff, our firm strives to provide the highest quality of service to our clients. We treat each case with careful attention to ensure that consumers get the justice they deserve. KSG is centrally located in Philadelphia, PA.